ArticleJournal for immunotherapy of cancer2020

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.

Kohei Shigeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.